Back to Search
Start Over
Preliminary experience with a hybrid nonthoracotomy defibrillating system that includes a biphasic device: Comparison with a standard monophasic device using the same lead system
- Source :
- Journal of the American College of Cardiology. (2):406-412
- Publisher :
- Published by Elsevier Inc.
-
Abstract
- Objectives. This study analyzed the advantage of combining a biphasic device with a transvenous system and compared the results with those obtained with a standard monophasic device. Background. Available lead system use monophasic pulses and may require lengthy intraoprative testing to achieve adequate defibrillation threshold in a conspicuous number of patients. The option of biphasis waveform may provide further benefits. However, clinical experience with a permanent implant is lacking. Methods. Fifty-five patients underwent testing and received a permanent implant using the Endotak lead system associated with a CPI monophasic device. The remaining 36 patients received a permanent implant with the Endotak lead system connected to a biphasic device. In both groups a subcutaneous patch was combined when needed to obtain acceptable defibrillation thresholds. Results. Biphasic pulses resulted in lower mean (±SD) defibrillation threshold (monophasic 15 ± 4.7 J vs. biphasic 12 ± 5 J, p = 0.03) and a better implantation rate (100% biphasic vs. 89% monophasic, p = 0.07). Biphasic pulses allowed implantation with less ventricular fibrillation induction (7.4 ± 3.2 vs. 3.5 ± 1.8, p < 0.01) and a mean shorter procedure time (168 ± 39 vs. 111 ± 30 min, p < 0.01). With the biphasic waveform a grater proportion of patients met the implantation criteria with the lead system alone (83% vs. 45%, p < 0.01). When needed, the left prepectoral location of the patch electrode was always sufficient in patients receiving the biphasic device, whereas placement in the left subscapular position was required in 15 patients in the monophaisic group. Implantation of the biphasic device was associated with a shorter mean hospital stay (3.8 ± 0.8 vs. 5.4 ± 2.2 days, p < 0.01). Conclusions. Incorporation of a biphasic device in a transvenous implantable cardioverter-defibrillator uniformly incresses the efficacy of the system and the case of implantation.
- Subjects :
- Adult
Male
medicine.medical_specialty
Defibrillation
medicine.medical_treatment
Electric Countershock
Defibrillation threshold
Patch electrode
Medicine
Humans
In patient
Procedure time
Aged
business.industry
Lead system
Biphasic waveform
Equipment Design
Middle Aged
medicine.disease
Surgery
Defibrillators, Implantable
Electrodes, Implanted
Heart Arrest
Thoracotomy
Anesthesia
Ventricular fibrillation
Tachycardia, Ventricular
Female
business
Cardiology and Cardiovascular Medicine
Subjects
Details
- Language :
- English
- ISSN :
- 07351097
- Issue :
- 2
- Database :
- OpenAIRE
- Journal :
- Journal of the American College of Cardiology
- Accession number :
- edsair.doi.dedup.....81ca9377dc582c7cf3ffb409d52f6ca0
- Full Text :
- https://doi.org/10.1016/0735-1097(94)90295-X